Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 107, Issue 1, Pages 154-170Publisher
WILEY
DOI: 10.1002/cpt.1643
Keywords
-
Categories
Funding
- National Institutes of Health [R24GM123930]
- PharmGKB [R24GM61374]
Ask authors/readers for more resources
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP2D6 gene locus. CYP2D6 genetic variation impacts the metabolism of numerous drugs and, thus, can impact drug efficacy and safety. This GeneFocus provides a comprehensive overview and summary of CYP2D6 genetic variation and describes how the information provided by PharmVar is utilized by the Pharmacogenomics Knowledgebase (PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
